BSF ENTERPRISE PLC

AGM Information • Mar 5, 2025

National Storage Mechanism | Additional information

RNS Number : 4883Z

BSF Enterprise PLC

05 March 2025

5 March 2025

BSF Enterprise PLC

("BSF" or the "Company")

Result of Annual General Meeting

BSF Enterprise (BSFE), through its 3D Bio-Tissues (3DBT) subsidiary, is transforming the biotech landscape with innovative technologies that include scaffold-free tissue engineered materials and patented macromolecular crowders, used as media additives to optimize cell growth.

The Company is pleased to announce that at the Company's Annual General Meeting held earlier today, all resolutions proposed were duly passed by shareholders by way of a poll, the results of which were as follows:

Resolution		Poll Results
For	Against	Withheld	Discretionary	Total
1	Shares	74,812,766	-	-	-	74,812,766
%	100.00%	-	-	-	100%
2	Shares	73,512,766	1,309,210	10,000	-	74,831,976
%	98.24%	1.75%	-	-	100%
3	Shares	73,512,766	1,309,210	10,000	-	74,831,976
%	98.24%	1.75%	-	-	100%
4	Shares	60,137,512	1,756,487	10,000	-	61,903,999
%	97.15%	2.84%		-	100%
5	Shares	73,512,766	1,309,210	10,000	-	74,831,976
%	98.24%	1.75%	0.01%	-	100%
6	Shares	74,812,766	-	19,210	-	74,831,976
%	99.97%	-	-	-	100%
7	Shares	73,060,970	1,751,796	19,210	-	74,831,976
%	97.63%	2.34%	-	-	100%
8	Shares	73,065,489	1,747,277	19,210	-	74,831,976
%	97.64%	2.33%	0.03%		100%
9	Shares	74,812,766	-	19,210	-	74,831,976
%	99.97%	-	0.03%	-	100%

About BSF Enterprise PLC:

BSF Enterprise PLC (BSF) is the parent to a portfolio of innovative subsidiary companies focused on developing and commercialising cell-based tissue engineering solutions to deliver sustainable outcomes across a variety of sectors. Its portfolio of subsidiaries is as follows:

-     3DBT : A pioneering UK-based tissue engineering company that has developed scaffold-free tissue production processes as well as leading on the commercial use of macromolecular  crowders to transform cell culture.

-     Lab-Grown Leather Ltd : A company focused on the customer driven development of cultivated skin technology to produce sustainable leather.

-     Kerato Ltd : A tissue engineering company with patent-protected IP that is focussing on commercialising technologies for corneal repair with veterinary trials starting 2025 .

-     BSF Enterprise (Hong Kong) Limited : A company established to actively support commercialisation of BSF's technology in China and Asia. 

-     Cultured Meat Technologies (CMT): A 100% owned company, using technology developed within 3DBT, successfully produced the UK's first high-quality cultivated meat. Currently focused on providing the market with the premier platform for manufacturing cultivated meat in a scalable and cost-competitive manner.

BSF's core strategy is to acquire, invest in, or develop joint ventures with, the most promising companies from across the industry. In doing so BSF intends to create an environment in which its portfolio of companies can flourish and collaborate, thereby accelerating their progress, potential and time to market.

For further enquiries, please visit www.bsfenterprise.com or contact:

Geoff Baker - Executive Director

Che Connon - CEO & Director

Shard Capital (Broker):

Damon Heath 0207 186 9000

Isabella Pierre 0207 186 9927

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGJAMBTMTAMBAA